Treace Medical Concepts, Inc.
TMCI
$1.24
-$0.07-5.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 24.51% | 5.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 24.51% | 5.97% | |||
| Cost of Revenue | 15.32% | 9.06% | |||
| Gross Profit | 26.94% | 5.18% | |||
| SG&A Expenses | 4.18% | 0.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.47% | 0.82% | |||
| Operating Income | 59.65% | 13.54% | |||
| Income Before Tax | 42.33% | 6.38% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 42.33% | 6.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 42.33% | 6.38% | |||
| EBIT | 59.65% | 13.54% | |||
| EBITDA | 65.42% | 17.36% | |||
| EPS Basic | 42.63% | 7.14% | |||
| Normalized Basic EPS | 56.65% | 12.86% | |||
| EPS Diluted | 42.63% | 7.14% | |||
| Normalized Diluted EPS | 56.65% | 12.86% | |||
| Average Basic Shares Outstanding | 0.54% | 0.81% | |||
| Average Diluted Shares Outstanding | 0.54% | 0.81% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||